Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3048

Actual shortage: 226 (7%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2799 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-IBUPROFEN 200MG TABLET Resolved 2024-03-01 2024-03-29 221087
APO-IBUPROFEN 400MG TABLET Resolved 2024-03-15 2024-04-05 222470
APO-HYDROXYUREA 500MG CAPSULE Resolved 2017-08-14 2017-12-07 19129
APO-HYDROXYUREA 500MG CAPSULE Resolved 2019-08-08 2020-06-24 91143
APO-HYDROXYUREA 500MG CAPSULE CAPSULE Resolved 2020-08-14 2020-11-18 122276
APO-HYDROXYUREA 500MG CAPSULE CAPSULE Resolved 2022-12-09 2023-01-31 177609
APO-HYDROXYUREA 500MG CAPSULE CAPSULE Resolved 2023-02-02 2023-02-09 183489
APO-HYDROXYUREA 500MG CAPSULE CAPSULE Resolved 2023-08-18 2023-09-12 202406
APO-HYDROXYQUINE 200MG TABLET Resolved 2017-09-04 2017-11-20 20875
APO-HYDROXYQUINE 200MG TABLET Resolved 2020-03-20 2020-04-24 109087
APO-HYDROXYQUINE 200MG TABLET Actual shortage 2024-05-24 2024-05-24 228780
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Resolved 2019-01-03 2020-04-04 71124
APO-HYDROMORPHONE CR 9MG CAPSULE (EXTENDED RELEASE) Resolved 2019-01-03 2020-04-04 71127
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Resolved 2019-01-30 2020-04-04 74019
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77849
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77852
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77855
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77858
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-20 2020-04-04 79039
APO-HYDROMORPHONE CR 4.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-11-13 2020-04-04 98562

Showing 1781 to 1800 of 3048

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RISEDRONATE 35MG TABLET Discontinued 2018-09-08 2018-09-15 60747
APO-RISEDRONATE 35MG TABLET Discontinued 2018-10-19 2018-10-19 64965
APO-RILUZOLE 50MG TABLET To be discontinued 2018-09-08 2018-09-08 60744
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RANITIDINE TABLET 300MG 300MG TABLET Discontinued 2018-09-08 2018-09-15 60729
APO-RANITIDINE TABLET 300MG 300MG TABLET To be discontinued 2018-09-08 2018-09-08 60732
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2019-02-13 60723
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2018-12-28 60726
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2019-01-02 2019-01-09 70810
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2018-02-23 2019-09-12 40805
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2018-09-08 2018-10-05 60717
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-QUININE 200MG CAPSULE Discontinued 2018-09-08 2021-05-10 60711
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714
APO-QUETIAPINE 300MG TABLET Discontinued 2018-09-08 2018-12-28 60708
APO-QUETIAPINE 25MG TABLET Discontinued 2020-07-10 2020-07-10 119950

Showing 81 to 100 of 356